Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone agonist with or without growth hormone

PURPOSE: There is controversy surrounding the growth outcomes of treatment with gonadotropin-releasing hormone agonist (GnRHa) in central precocious puberty (CPP). We analyzed height preservation after treatment with GnRHa with and without growth hormone (GH) in girls with CPP. METHODS: We reviewed...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Mo Kyung, Song, Kyung Chul, Kwon, Ah Reum, Chae, Hyun Wook, Kim, Duk Hee, Kim, Ho-Seong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Pediatric Endocrinology 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4316408/
https://www.ncbi.nlm.nih.gov/pubmed/25654068
http://dx.doi.org/10.6065/apem.2014.19.4.214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4316408/
https://www.ncbi.nlm.nih.gov/pubmed/25654068
http://dx.doi.org/10.6065/apem.2014.19.4.214

Ejemplares similares